#Canada #cancer therapy #Toronto #antibody-drug conjugates #Xtalks Webinar

Navigating the ADC Clinical Trial Landscape

In the ever-evolving field of oncology, antibody-drug conjugates (ADCs) are increasingly recognized as a pivotal tool in targeted cancer treatment. With 15 ADCs already approved worldwide and over 400 still in various stages of development, the potential for improved patient outcomes is substantial. However, the path to success in ADC clinical trials is fraught with complexities requiring meticulous attention to safety profiles and operational protocols.

Join the Upcoming Webinar

On January 29, 2026, Xtalks will host a comprehensive webinar titled "Operationalizing ADC Clinical Trials: Best Practices for Success." This session is geared toward providing participants with essential insights into the ADC therapeutic pipeline and global site selection, emphasizing the critical elements needed for successful trial execution.

Experts Ashley Herrick, PhD, Vice President of Oncology Program Strategy, and Jordan Curry, Senior Project Director in Oncology at Premier Research, will lead attendees through a variety of key topics related to ADC trials. This engagement will focus on:

• - Dose Optimization Strategies: Applying Project Optimus principles to enhance trial design concerning dosages that ensure patient safety and efficacy.
• - Global Site Selection Preparedness: Understanding the essential criteria for selecting appropriate sites for trials and the groundwork necessary for optimal site training.
• - Patient Education and Safety Monitoring: Utilizing ADC-specific educational tools along with robust toxicity management strategies to ensure patient wellbeing.

The Importance of Patient Involvement

Incorporating the patient voice into protocol development is vital, and this webinar will highlight methods to engage patients effectively. By understanding patient experiences and preferences, researchers can enhance feasibility assessments for ADC therapies.

Recruitment and retention are critical metrics in clinical trial success, and this discussion will cover how biomarker-driven enrollment, streamlined screening processes, and minimal procedural burdens can improve the patient experience while maximizing operational efficiency.

Register Today

Don't miss the chance to glean invaluable knowledge from industry thought leaders on how to navigate the intricate landscape of ADC clinical trials. Attending this webinar could mean the difference between a successful trial and one that misses its mark. Register now to secure your spot for an event that promises to elevate your understanding and operational strategies regarding ADCs.

For more details and to register, visit the Xtalks webinar page.

Join us on January 29, 2026, at 11 AM EST (5 PM CET) and transform your approach to ADC clinical trials. Elevate your practice and contribute to a future where cancer treatments continue to evolve and improve patient outcomes.